Robert J.

Biography

Dr. Robert J. Rosenthal, also known as Bob, Ph.D., has been the Chief Executive Officer of Taconic Biosciences, Inc., since June 2, 2014. Bob served as the Chief Executive Officer at Tonoga Inc. He is also a Director of Taconic Biosciences. Dr. Rosenthal served as the Vice President of Communications and Marketing at Impact Online, Inc. He serves as the President at MolecularWare. Bob served as the Chief Executive Officer at IMI Intelligent Medical Implants AG since April 2010 and served as its Managing Director. He served as the President and Chief Executive Officer at Boston Life Sciences. Dr. Rosenthal served as Director of Communications at Impact Online, Inc. He founded Magellan Diagnostics, Inc. (alternate name, Magellan Biosciences Inc.) in 2004 and served as its President and Chief Executive Officer from October 2005 to February 2010. Bob served as the Chief Executive Officer and President at ESA Biosciences, Inc. From October 2003 to January 2007, he served as the President and Chief Executive Officer at Hamilton Storage Technologies, Inc. Dr. Rosenthal served as the President at PerkinElmer's Instruments division and managed the acquisition and integration of the Analytical Instruments group from PE Corporation. He served as the Chief Executive Officer at Alseres Pharmaceuticals, Inc. since March 2003 and its President since July 2002. Bob served as the Chief Operating Officer at Alseres Pharmaceuticals, Inc. From January 2001 to July 2002, he served as the President and Chief Executive Officer at Magellan Discovery Technologies LLC. From March 1999 to December 2000, Dr. Rosenthal served as the President at the Instrument Group and Senior Vice President of the Instruments Division at PerkinElmer Inc., where he managed the acquisition and integration at the Analytical Instruments group from PE Corporation. From August 1995 to March 1999, Bob served several positions at ThermoOptek Corp., including Chief Executive Officer and President. He held a senior management positions at Thermo Fisher Scientific, Inc. He held various executive positions at Thermo Optek Corporation from September 1995 to February 1999. As the President and Chief Executive Officer at Thermo Optek, he built a market- leading instrument company, which went public in 1996. Dr. Rosenthal served as the President at Nicolet Instrument Corporation. He served as a Vice President at Thermo Instrument Systems Inc. Bob has been the Chairman of Safeguard Scientifics, Inc. since May 19, 2016 and an Independent Director of Safeguard Scientifics, Inc. since July 2007. He has been a Director of ESA Biosciences, Inc., since June 2004. 

Research Interest

 Dr. Rosenthal has been a Director of Bruker Corporation since November 11, 2015. He has been a Director of Matritech Inc., since January 22, 2007. Bob serves as a Director of GeneXP Biosciences Inc., and MolecularWare. Dr. Rosenthal is a Member of the Board of Advisors to the University of Maryland Department of Chemistry and Biochemistry. He is also a Member of the University of Maryland, College of Chemical and Life Sciences Board of Visitors. Bob serves as Director of Galvanic Applied Sciences, Inc. He serves on several others, including the Board of Cambrius, Inc. Dr. Rosenthal serves as a Director of Protedyne. He served as a Director of Magellan Diagnostics, Inc. since October 2005. Bob served as a Director of MZT Holdings, Inc. from January 22, 2007 to January 22, 2008. He served as the Chairman of Board of Sensorin, Inc. since January 2012. Dr. Rosenthal served as the Chairman of Intelligent Medical Implants AG. He served as a Director of Hamilton Storage Technologies, Inc. from October 2003 to January 2007; IMI Intelligent Medical Implants AG; and Alseres Pharmaceuticals, Inc. since 2002. Bob served as a Director at PrimeraDx, Inc. He has 30 years of experience building value for customers, shareholders and employees in companies serving the biomedical research and diagnostics industries. Dr. Rosenthal holds Ph.D in Physical Chemistry from Emory University, M.S. in Chemistry from State University of New York (Buffalo), and a B.S. in Chemistry from the University of Maryland. He spent a year in Germany and a post-doctoral fellowship and as guest scientist of the Alexander von Humboldt Foundation. This was followed by Additional post-doctoral fellowship at University of California-Los Angeles. Bob holds AEA Executive MBA from Stanford University.